You are here

Article Text

Article menu
Download PDFPDF
Case Reports: Rare disease
Cervical carcinosarcoma: approach of a rare tumour in a rare location
  1. Cecília Caramujo1,
  2. Sara Nunes Reis2,
  3. Rui Vale Marques3 and
  4. Gabriela Sousa1
  1. 1Medical Oncology, Instituto Português de Oncologia de Coimbra Francisco Gentil EPE, Coimbra, Portugal
  2. 2Pathology, Instituto Português de Oncologia de Coimbra Francisco Gentil EPE, Coimbra, Portugal
  3. 3Radiotherapy, Instituto Português de Oncologia de Coimbra Francisco Gentil EPE, Coimbra, Portugal
  1. Correspondence to Dr Cecília Caramujo; ce.caramujo{at}gmail.com

Abstract

Cervical carcinosarcoma is a very rare tumour, with less than 70 cases described in the literature. We report a case of a woman in her 60s, with an atypical presentation: a single episode of high volume serous vaginal discharge. A carcinosarcoma of the uterine cervix was diagnosed and, after exclusion of distant disease, the patient was submitted to radical surgery. Due to surgical complications adjuvant treatment was not performed.

  • Obstetrics and gynaecology
  • Gynecological cancer
  • Oncology
  • Radiotherapy

https://doi.org/10.1136/bcr-2022-249302

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors Supervised by RM. Patient was under the care of RM. Report was written by CC and SR. Pathology images were selected by SR. Reviewd by GS.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.